✦ LIBER ✦

Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin ANtagonist in CHF patients undergoing Exercise) trial

✍ Scribed by Stuart D. Russell; Paulina Selaru; David A. Pyne; Maha M. Ghazzi; Kenneth D. Massey; Milton Pressler; Alexis Serikoff; Andrew J.S. Coats

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale and design of a randomised con

✍ Ana Zuazagoitia; Gonzalo Grandes; Jesús Torcal; Iñaki Lekuona; Pilar Echevarria; 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 423 KB

Evaluation of a novel antiplatelet agent

✍ David A. Morrow; Benjamin M. Scirica; Keith A.A. Fox; Gail Berman; John Strony; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 329 KB

Methods for economic evaluation of a fac

✍ Damian G Walker; Cristian Aedo; Cecilia Albala; Elizabeth Allen; Alan D Dangour; 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 305 KB

Rationale and design of the eXplore the

✍ Ezekowitz, Michael D.; Cappato, Riccardo; Klein, Allan L.; Camm, A. John; Ma, Ch 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Design of the muscles in motion study: a

✍ Esther A Habers, Marco van Brussel, Anneli C Langbroek-Amersfoort, Annet van Roy 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 278 KB

Rationale, design and baseline character

✍ David M. Ansley; Koen Raedschelders; David D.Y. Chen; Peter T. Choi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 249 KB